AVP and stroke disorder: Within the last few years, a role for Copeptin as a risk predictive biomarker in the management of acute myocardial infarction, chronic heart failure, stroke as well as chronic kidney disease (CKD) has been reported, but perioperative data are sparse [6,7,8,9].